My watch list
my.bionity.com  
Login  
NEWS
Current news

Merck on Track with Pharma Strategy

Merck announced that its biopharmaceutical division Merck Serono is well on track with the implementation of the Group’s “Fit for 2018” transformation and growth program. This is reflected by efficiency gains and the successful execution of growth initiatives as well as progress in the pipe ... more

Boehringer Ingelheim and CureVac announce collaboration to develop next generation lung cancer immunotherapy

Boehringer Ingelheim and CureVac, leader in mRNA (messenger ribonucleic acid)-based drug development, today jointly announce an exclusive global license and development collaboration. The new collaboration focuses on CureVac’s CV9202, a novel investigational therapeutic mRNA vaccine in earl ... more

A new piece in the autism puzzle

Disorders such as autism are often caused by genetic mutations. Such mutations can change the shape of protein molecules and stop them from working properly during brain development. However, the genetic foundation of autism is complicated and there is no single genetic cause. In some indiv ... more

Merck Strengthens Executive Board

Merck announced that the Board of Partners has promoted Stefan Oschmann (57) to the position of Deputy CEO and Vice Chairman of the Executive Board. Concurrently, Belén Garijo (54) was appointed to the Executive Board to take over leadership for the Pharma business. The management changes w ... more

Large study reveals new genetic variants that raise risk for prostate cancer

In an analysis of genetic information among more than 87,000 men, a global team of scientists says it has found 23 new genetic variants – common differences in the genetic code -- that increase a man's risk for prostate cancer. The so-called "meta-analysis," believed to be the largest of it ... more

Evotec takes legal steps against Andromeda Biotech, Ltd.

Evotec AG announced after careful evaluation that it will take legal steps against Israel-based Andromeda Biotech, Ltd. to recover all Evotec claims and potential damages that result from recent incidents in relation to DiaPep277®. On 08 September 2014, US-based Hyperion Therapeutics, Inc. ... more

Merck Serono and Sutro Biopharma to Partner on Development of Antibody Drug Conjugates

Merck Serono and Sutro Biopharma, San Francisco, a biopharmaceutical company developing antibody drug conjugates and bispecific antibodies, announced a collaboration and license agreement to develop antibody drug conjugates (ADCs). ADCs are composed of an antibody linked to a cytotoxic drug ... more

'Office life' of bacteria may be their weak spot

Scientists at the University of Leeds think we may be able to drown deadly bacteria in their own paperwork. A research team in the University's Astbury Centre for Structural Molecular Biology has identified for the first time how the "paper shredder" that keeps the bacteria E. coli on top o ... more

New diagnostic method identifies genetic diseases

People with genetic diseases often have to embark on an odyssey from one doctor to the next. Fewer than half of all patients who are suspected of having a genetic disease actually receive a satisfactory diagnosis. Scientists from the Charité - Universitätsmedizin Berlin and the Max Planck I ... more

Bayer plans to focus entirely on Life Science businesses

Bayer intends in the future to focus entirely on the Life Science businesses – HealthCare and CropScience – and float MaterialScience on the stock market as a separate company. In this way Bayer is positioning itself as a world-leading company in the field of human, animal and plant health. ... more

All news

Gibbon genome sequenced

An international team of researchers that includes Christian Roos, Markus Brameier and Lutz Walter from the German Primate Center (DPZ) in Göttingen, have decoded the genome of gibbons from Southeast Asia. With this, the entire genetic information of five different species of this primate f ... more

Highly automated live cell imaging speeds up the search for new drugs

Fraunhofer FIT will present the latest version of its Zeta Fluorescence Image Analysis software at MipTec. Zeta, now extended to a software platform, supports the complete work process of finding new pharmaceutical agents. At MipTec, Fraunhofer FIT will demo advanced Zeta applications in ca ... more

Is the Ebola Virus a Real Threat for Europe and the US?

“The Zaire Ebola virus causes a highly contagious and lethal hemorrhagic fever leading to the death of the infected individuals. The recent outbreak of the virus in West Africa has alarmed the world, especially Europe and the US, owing to the geographical speed of the infection spread and h ... more

Malvern Instruments completes acquisitions

Malvern Instruments Ltd has announced that it has completed the acquisition of MicroCal from GE Healthcare Life Sciences and has also purchased the Archimedes particle characterization system from Affinity Biosensors LLC (Santa Barbara, CA). Both of these developments extend Malvern’s portf ... more

QIAGEN adds promising genomic biomarkers to pipeline

QIAGEN N.V. announced it has acquired an exclusive global license to the biomarker SF3B1 from the University of Tokyo. SF3B1 is believed to play a critical role in the prognosis of patients with myelodysplastic syndromes (MDS), a group of hematological cancers in which bone marrow does not ... more

Zenith Epigenetics Appoints Julie Cherrington as President and CEO

Zenith Epigenetics Corp. announced that it has appointed Julie Cherrington PhD to act as the President and Chief Executive Officer of Zenith Epigenetics Corp. Julie has an extensive background leading companies focused on the discovery and development of novel cancer therapeutics and is wel ... more

GENALICE and deCODE Genetics enter into a partnership for population wide genomic analysis

GENALICE announced it is partnering with deCODE Genetics to facilitate the large-scale testing of its unique DNA data processing software solution, GENALICE MAP. After a first successful round of evaluating GENALICE MAP on speed and quality, both parties agreed to extend the evaluation to i ... more

Ötzi’s “non-human” DNA

Ötzi’s human genome was decoded from a hip bone sample taken from the 5,300 year old mummy. However the tiny sample weighing no more than 0.1 g provides so much more information. A team of scientists from EURAC in Bolzano/Bozen together with colleagues from the University of Vienna successf ... more

Pseudogenes may provide clearer understanding of biomarkers

Alas, the thankless pseudogene. Dysfunctional, unloved and seemingly of little use, these poor-cousin relatives of genes have lost their protein-coding abilities. They contain material not essential for an organism's survival and are the "last stop" for removal of genomic waste. Not any mor ... more

Identifying microbial species

Millions of microbial species populate the world, but so far only a few have been identified due to the inability of most microbes to grow in the laboratory. Edgar Goluch, an engineer, and Slava Epstein, a biologist, aim to change this. The pair, both researchers at Northeastern University, ... more

All news on bioanalytics

BASF, Cargill and Novozymes achieved another milestone in bio-based acrylic acid

BASF, Cargill and Novozymes announced the achievement of another milestone in their joint development of technologies to produce acrylic acid from renewable raw materials. The team has demonstrated the successful conversion of 3-hydroxypropionic acid (3-HP), to glacial acrylic acid and supe ... more

Diabetes researchers find faster way to create insulin-producing cells

University of British Columbia, in collaboration with BetaLogics Venture, a division of Janssen Research & Development, LLC, has published a study highlighting a protocol to convert stem cells into insulin-producing cells. The new procedure could be an important step in the fight against Ty ... more

Central biobank for drug research

For the development of new drugs it is crucial to work with stem cells, as these allow scientists to study the effects of new active pharmaceutical ingredients. But it has always been difficult to derive enough stem cells of the right quality and in the right timeframe. A central biobank is ... more

IMGM Laboratories GmbH announces the appointment of Dr. Michael Bonin as Managing Director

The genomic service provider IMGM Laboratories GmbH is pleased to announce Dr. Michael Bonin (40) as additional Managing Director effective August 1st 2014. Michael Bonin will head the scientific and technical development of the IMGM Laboratories GmbH activities and will direct the business ... more

Cenix BioScience and Metanomics Health sign research agreement

Cenix BioScience GmbH announced that it has signed a research framework agreement with Metanomics Health GmbH, a BASF Group company, focused on comprehensive metabolite profiling services and the development of metabolomic biomarkers.  As the agreement’s first work assignment, Metanomics He ... more

Miriam Monge to Join Sartorius Stedim Biotech as Director

Sartorius Stedim Biotech (SSB) announced the appointment of Miriam Monge as Director of Marketing for SSB’s Integrated Solutions unit. In this newly created position, Monge will focus on sharpening SSB’s profile as an integrated solution provider for the biopharmaceutical industry. Miriam M ... more

Removing programming material after inducing stem cells could improve their regeneration ability

Human induced pluripotent stem cells (hiPSCs) have great potential in the field of regenerative medicine because they can be coaxed to turn into specific cells; however, the new cells don’t always act as anticipated. They sometimes mutate, develop into tumors or produce other negative side ... more

Messe München International takes over one of India's leading trade fairs for laboratory technology

Messe München International is strengthening its portfolio of events in the future market of India by taking over India Lab Expo, one of the leading trade fairs for laboratory technology, analysis and biotechnology on the Indian subcontinent. For the first time ever, this year's India Lab E ... more

Researchers block plant hormone

Researchers trying to get new information about the metabolism of plants can switch off individual genes and study the resulting changes. However, Erich Kombrink from the Max Planck Institute for Plant Breeding Research in Cologne and Markus Kaiser from the University of Duisburg-Essen adop ... more

Efficient production of hydrogen by algae

Microalgae need only sunlight and water for the production of hydrogen. However, in order to make hydrogen production by microalgae economically feasible their efficiency has to be increased by 1-2 orders of magnitude. In the current issue of Energy and Environmental Science scientists from ... more

All news on biotechnology

New diagnostic method identifies genetic diseases

People with genetic diseases often have to embark on an odyssey from one doctor to the next. Fewer than half of all patients who are suspected of having a genetic disease actually receive a satisfactory diagnosis. Scientists from the Charité - Universitätsmedizin Berlin and the Max Planck I ... more

The shadow of a disease

In future, some diseases might be diagnosed earlier and treated more effectively. Researchers at the Max Planck Institute for the Science of Light in Erlangen have developed an optical method that makes individual proteins, such as the proteins characteristic of some cancers, visible. Other ... more

Mice and men share a diabetes gene

A joint work by EPFL, ETH Zürich and the CHUV has identified a pathological process that takes place in both mice and humans towards one of the most common diseases that people face in the industrialized world: type 2 diabetes. This work was conducted in Johan Auwerx's (EPFL) and Ruedi Aebe ... more

Electronic nose can detect sub-groups of asthma in children

An electronic nose can be used to successfully detect different sub-groups of asthmatic children, according to a new study. The new research, presented at the European Respiratory Society (ERS) International Congress in Munich (7 September 2014), is part of the U-BIOPRED (Unbiased biomarker ... more

Food analysis and diagnostics are hot topics at analytica China 2014

analytica China, International Trade Fair for Laboratory Technology, Analysis, Biotechnology and Diagnostics, opens its gates at the Shanghai New International Expo Centre (SNIEC) for the seventh time from September 24–26, 2014. This year's focus topics are food analysis and diagnostics. Am ... more

Faster, cheaper tests for sickle cell

Within minutes after birth, every child in the U.S. undergoes a battery of tests designed to diagnose a host of conditions, including sickle cell disease. Thousands of children born in the developing world, however, aren't so lucky, meaning many suffer and die from the disease each year. A. ... more

Predemtec GmbH receives seed financing for developing a blood test to diagnose Alzheimer`s Disease

Predemtec GmbH develops a blood test for a reliable diagnosis of Alzheimer’s disease. In July 2014 the start-up received a seed financing from High-Tech Gruenderfonds (HTGF). The seed investment will be used to finalize the first test into a marketable product and to expand the scope of the ... more

QIAGEN adds promising genomic biomarkers to pipeline

QIAGEN N.V. announced it has acquired an exclusive global license to the biomarker SF3B1 from the University of Tokyo. SF3B1 is believed to play a critical role in the prognosis of patients with myelodysplastic syndromes (MDS), a group of hematological cancers in which bone marrow does not ... more

Implandata Announces Successful Implantation of Micro-Sensor for Intraocular Pressure Measurement in Glaucoma Patient

Implandata Ophthalmic Products GmbH reports the successful implantation of the first patient within the ARGOS-02 clinical study at Augenklinik Bellevue in Kiel, Germany.  In the ARGOS-02 clinical study, six eye centers in Germany are currently recruiting primary open angle glaucoma patients ... more

Dangers of desert dust: New diagnostic tool for valley fever

On July 5, 2011, a massive wall of dust, ("haboob," in Arabic), blanketed Phoenix, Arizona, creating an awesome spectacle, (or stubborn nuisance, depending on your perspective). Dust storms are a common occurrence in the arid desert environments of the American Southwest. But windborne dust ... more

All news on diagnostics

Messe München International takes over one of India's leading trade fairs for laboratory technology

Messe München International is strengthening its portfolio of events in the future market of India by taking over India Lab Expo, one of the leading trade fairs for laboratory technology, analysis and biotechnology on the Indian subcontinent. For the first time ever, this year's India Lab E ... more

Bochem Increasingly Using New Media

Bochem Instrumente GmbH presents sections of its overall product spectrum in various new videos. The recently finished productions provide a compact overview of the product groups of lab jacks, electrical lifts, containers as well as stands and clamps. They can be found on the company’s web ... more

Merger of CyBio AG into Analytik Jena AG Completed

The merger of CyBio AG into Analytik Jena AG became effective upon entry into the commercial register of Analytik Jena AG (commercial register of the Registry Court of Jena, HRB 200027). As a result, CyBio AG is dissolved as an independent company. In the future, the Life Science business u ... more

LABVOLUTION – the new lab technology show in Hannover

Deutsche Messe is launching LABVOLUTION, a new trade fair to be staged every two years as amajor platform for the world of lab technology and equipment. LABVOLUTIONmakes its debut from 6 to 8 October 2015 at the Hannover Exhibition Center in Hannover, Germany, where it will take place every ... more

Automating Laboratory-On-A-Chip To Cut Healthcare Costs

A research team at the University of California, Riverside has created a computer programming language that will automate “laboratory-on-a-chip” technologies used in DNA sequencing, drug discovery, virus detection and other biomedical applications.“If you think of the beginning of computers ... more

Reorganization of the Executive Board of Eppendorf AG

The Executive Board of Eppendorf AG is reshaping in order to be optimally equipped to meet the future demands of the market. Dr. Dirk Ehlers, Chairman of the Executive Board of the Eppendorf Group, will leave the company by mutual agreement. Detmar Ammermann (Chief Financial Officer) will r ... more

New microscope sees what others can't

Microscopes don't exactly lie, but their limitations affect the truths they can tell. For example, scanning electron microscopes (SEMs) simply can't see materials that don't conduct electricity very well, and their high energies can actually damage some types of samples. In an effort to ext ... more

A lab in your pocket

When you get sick, your physician may take a sample of your blood, send it to the lab and wait for results. In the near future, however, doctors may be able to run those tests almost instantly on a piece of plastic about the size of credit card. These labs-on-a-chip would not only be quick— ... more

Sartorius with Gains

Sartorius got off to a good start in fiscal 2014, with gains in order intake and sales revenue. In constant currencies, Group sales revenue rose 6.3% and order intake increased 4.9%. Despite negative currency impacts, operating Profit for the Group also grew 2.0%; its respective margin afte ... more

Turning smart phones into microscopes

Australian scientists have invented a simple and cheap way of making a high-powered lens that can transform a smart phone into a high-resolution microscope. Costing less than a cent, the lenses promise a revolution in science and medicine in developing countries and remote areas. The lens f ... more

All news on lab technology

Merck on Track with Pharma Strategy

Merck announced that its biopharmaceutical division Merck Serono is well on track with the implementation of the Group’s “Fit for 2018” transformation and growth program. This is reflected by efficiency gains and the successful execution of growth initiatives as well as progress in the pipe ... more

Boehringer Ingelheim and CureVac announce collaboration to develop next generation lung cancer immunotherapy

Boehringer Ingelheim and CureVac, leader in mRNA (messenger ribonucleic acid)-based drug development, today jointly announce an exclusive global license and development collaboration. The new collaboration focuses on CureVac’s CV9202, a novel investigational therapeutic mRNA vaccine in earl ... more

Merck Strengthens Executive Board

Merck announced that the Board of Partners has promoted Stefan Oschmann (57) to the position of Deputy CEO and Vice Chairman of the Executive Board. Concurrently, Belén Garijo (54) was appointed to the Executive Board to take over leadership for the Pharma business. The management changes w ... more

Evotec takes legal steps against Andromeda Biotech, Ltd.

Evotec AG announced after careful evaluation that it will take legal steps against Israel-based Andromeda Biotech, Ltd. to recover all Evotec claims and potential damages that result from recent incidents in relation to DiaPep277®. On 08 September 2014, US-based Hyperion Therapeutics, Inc. ... more

Merck Serono and Sutro Biopharma to Partner on Development of Antibody Drug Conjugates

Merck Serono and Sutro Biopharma, San Francisco, a biopharmaceutical company developing antibody drug conjugates and bispecific antibodies, announced a collaboration and license agreement to develop antibody drug conjugates (ADCs). ADCs are composed of an antibody linked to a cytotoxic drug ... more

Bayer plans to focus entirely on Life Science businesses

Bayer intends in the future to focus entirely on the Life Science businesses – HealthCare and CropScience – and float MaterialScience on the stock market as a separate company. In this way Bayer is positioning itself as a world-leading company in the field of human, animal and plant health. ... more

MorphoSys Receives Research Grant to Develop Novel Therapeutic Antibodies Targeting GPCRs

MorphoSys AG announced the receipt of a grant of up to EUR 1 million from the German Federal Ministry of Education and Research (BMBF), comprising funding for two of its therapeutic antibody programs. The funding will support the company in developing Ylanthia antibodies against two undiscl ... more

Evotec and the Jain Foundation expand collaboration

Evotec AG and the Jain Foundation Inc. announced that they have further extended and expanded the collaboration first signed in 2012 and extended last year. This next phase of collaboration includes the screening of compound libraries in multiple assay formats to further support the Jain Fo ... more

Merck Discontinues Clinical Development Program of Tecemotide

Merck announced that its biopharmaceutical division Merck Serono will discontinue the clinical development program of its investigational MUC1 antigen-specific cancer immunotherapy tecemotide (also known as L-BLP25) as a monotherapy in Stage III non-small cell lung cancer (NSCLC). Luciano R ... more

Evotec and CHDI Foundation extend ongoing collaboration to fight Huntington's disease

Evotec AG announced that CHDI Foundation, Inc. has extended and restated its collaboration with Evotec through 2017. The collaboration-which aims to find new treatments for Huntington's disease, an inherited neurodegenerative disorder-means that CHDI will fund up to 52 full-time scientistsa ... more

All news on pharma

A new piece in the autism puzzle

Disorders such as autism are often caused by genetic mutations. Such mutations can change the shape of protein molecules and stop them from working properly during brain development. However, the genetic foundation of autism is complicated and there is no single genetic cause. In some indiv ... more

Large study reveals new genetic variants that raise risk for prostate cancer

In an analysis of genetic information among more than 87,000 men, a global team of scientists says it has found 23 new genetic variants – common differences in the genetic code -- that increase a man's risk for prostate cancer. The so-called "meta-analysis," believed to be the largest of it ... more

Ebola outbreak 'out of all proportion' and severity cannot be predicated

A mathematical model that replicates Ebola outbreaks can no longer be used to ascertain the eventual scale of the current epidemic, finds research conducted by the University of Warwick. Dr Thomas House, of the University's Warwick Mathematics Institute, developed a model that incorporated ... more

Pathogens specifically target multi-function proteins

Proteins form either small or large networks to perform their functions. How these protein networks are subverted by pathogens, has been investigated on a plant model by a research team. Distinct pathogens like fungi and bacteria were found to use the same tactic, launching targeted attacks ... more

Sharks' skin has teeth in the fight against hospital superbugs

Transmission of bacterial infections, including MRSA and MSSA could be curbed by coating hospital surfaces with microscopic bumps that mimic the scaly surface of shark skin, according to research published in the open access journal Antimicrobial Resistance and Infection Control. The study ... more

Gene variant that dramatically reduces 'bad' lipids

Research using data collected from around 4,000 healthy people in the UK has enabled scientists to identify a rare genetic variant that dramatically reduces levels of certain types of lipids in the blood. The study is the first to emerge from the UK10K Project's cohort of samples from the g ... more

Phthalates heighten risk for childhood asthma

Researchers at the Columbia Center for Children's Environmental Health at the Mailman School of Public Health are the first to demonstrate an association between childhood asthma and prenatal exposure to two phthalates used in a diverse array of household products. Results appear online in ... more

Researchers debunk myth about Parkinson's disease

Using advanced computer models, neuroscience researchers at the University of Copenhagen have gained new knowledge about the complex processes that cause Parkinson's disease. The findings have recently been published in the Journal of Neuroscience. The defining symptoms of Parkinson's disea ... more

Cellular protein may be key to longevity

Researchers have found that levels of a regulatory protein called ATF4, and the corresponding levels of the molecules whose expression it controls, are elevated in the livers of mice exposed to multiple interventions known increase longevity. Elevation of ATF4, at least in the liver, seems ... more

Experts call for massive global response to tackle Ebola

The current Ebola outbreak now requires a "rapid response at a massive global scale", according to experts at the London School of Hygiene & Tropical Medicine. Writing an editorial in Science, Professor Peter Piot, co-discoverer of the virus, says that the epidemic in West Africa is the res ... more

All news on healthcare
News by department
News according to country
Companies in the news
News archive
Newsletters

bionity.com Newsletter

The bionity.com newsletter keeps you informed about the current events in the fields of biotechnology, life sciences and medicine with news, products, company profiles and technical information.
Current edition

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE